{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:46:23Z","timestamp":1782017183140,"version":"3.54.5"},"reference-count":17,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,5,12]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>The efficacy of continuous glucose monitors (CGM) to improve glycaemic control in individuals on intensive insulin therapy (basal and prandial) has been well established in several studies; however, there is limited evidence on its usage and efficacy in patients with type 2 diabetes (T2D) who are on non-insulin therapies. Lifestyle modifications and glucose monitoring are essential components of the management of T2D. We report a case that demonstrates the impact of CGM use as an effective tool for patient education and motivation to implement and adhere to lifestyle modifications in improving glycaemic control in a patient with long-standing poorly controlled T2D who was on oral glucose-lowering medications. CGM use is associated with high level of patient satisfaction which can improve quality of life and has the potential to reduce long-term complications related to poor glycaemic control. These observations emphasise the need to broaden the use of CGM in this patient population.<\/jats:p>","DOI":"10.1136\/bcr-2021-248579","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:11:23Z","timestamp":1654600283000},"page":"e248579","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Use of continuous glucose monitor as a motivational device for lifestyle modifications to improve glycaemic control in patients with type 2 diabetes treated with non-insulin therapies"],"prefix":"10.1136","volume":"15","author":[{"given":"Hisham Ahmed","family":"Farhan","sequence":"first","affiliation":[{"name":"Endocrinology, Medicine, University of Maryland Medical Center, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7343-0501","authenticated-orcid":false,"given":"Khulood","family":"Bukhari","sequence":"additional","affiliation":[{"name":"Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Grewal","sequence":"additional","affiliation":[{"name":"Medicine, American University of Antigua College of Medicine, Saint Johns, Antigua and Barbuda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sranita","family":"Devarasetty","sequence":"additional","affiliation":[{"name":"Department of Medicine, American University of Antigua, Osborne, Antigua and Barbuda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Munir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, University of Maryland Medical Center, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"2025082711470084000_15.6.e248579.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19975"},{"key":"2025082711470084000_15.6.e248579.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19976"},{"key":"2025082711470084000_15.6.e248579.3","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2855"},{"key":"2025082711470084000_15.6.e248579.4","doi-asserted-by":"crossref","first-page":"S-27","DOI":"10.1089\/dia.2021.0007","article-title":"Type 2 diabetes and the use of real-time continuous glucose monitoring","volume":"23","author":"Jackson","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2025082711470084000_15.6.e248579.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S007"},{"key":"2025082711470084000_15.6.e248579.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2756"},{"key":"2025082711470084000_15.6.e248579.7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","article-title":"American association of clinical endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus","volume":"27","author":"Grunberger","year":"2021","journal-title":"Endocr Pract"},{"key":"2025082711470084000_15.6.e248579.8","first-page":"e33","article-title":"Trends in insulin use and diabetes control in the U","volume":"39","author":"Selvin","year":"2016","journal-title":"S.: 1988-1994 and 1999-2012. Diabetes Care"},{"key":"2025082711470084000_15.6.e248579.9","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"key":"2025082711470084000_15.6.e248579.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.06.015"},{"key":"2025082711470084000_15.6.e248579.11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jdi.12807","article-title":"Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: a narrative review","volume":"9","author":"Taylor","year":"2018","journal-title":"J Diabetes Investig"},{"key":"2025082711470084000_15.6.e248579.12","unstructured":"Centers for Disease Control and Prevention . National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services, 2020."},{"key":"2025082711470084000_15.6.e248579.13","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S005"},{"key":"2025082711470084000_15.6.e248579.14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s13300-019-0619-1","article-title":"A view beyond HbA1c: role of continuous glucose monitoring","volume":"10","author":"Chehregosha","year":"2019","journal-title":"Diabetes Ther"},{"key":"2025082711470084000_15.6.e248579.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S006"},{"key":"2025082711470084000_15.6.e248579.16","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"2025082711470084000_15.6.e248579.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0166"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-248579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:47:07Z","timestamp":1756320427000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-248579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,7]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bcr-2021-248579"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-248579","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}